BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Cinnamomum zeylanicum {Ceylon Cinnamon} - Aspergillus niger |
📓
Evidence for synergistic activity of plant-derived essential oils against fungal pathogens of food. Food microbiology (Food Microbiol ) Vol: 53 Issue Pt B Pages: 24-30 Pub: 2016 Feb Epub: 2015 Aug 18 Authors Hossain F , Follett P , Dang Vu K , Harich M , Salmieri S , Lacroix M , Publication |
| Cinnamomum zeylanicum {Ceylon Cinnamon} - Aspergillus niger |
📓
Bioanalytical evaluation of Cinnamomum zeylanicum essential oil. Natural product research (Nat Prod Res ) Vol: 29 Issue 19 Pages: 1857-9 Pub: 2015 Epub: 2015 Jan 21 Authors Saleem M , Bhatti HN , Jilani MI , Hanif MA , Publication |
| Cinnamomum zeylanicum {Ceylon Cinnamon} - Aspergillus niger |
📓
TLC bioautography-guided isolation of essential oil components of cinnamon and clove and assessment of their antimicrobial and antioxidant potential in combination. Environmental science and pollution research international (Environ Sci Pollut Res Int ) Vol: 28 Issue 1 Pages: 1131-1140 Pub: 2021 Jan Epub: 2020 Aug 24 Authors Purkait S , Bhattacharya A , Bag A , Chattopadhyay RR , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
